The companies provided no specific reason for the abrupt termination of the deal, which would have served as the primary vehicle for Ignite Proteomics to debut on the stock exchange. Despite the dissolution, Copley Acquisition remains active in its search for a new target. The special purpose acquisition company faces a deadline of Nov. 2 to secure a fresh merger agreement, though its governing documents allow for potential extensions beyond that date.